Classes
- Internal Medicine - SE +1B00073 | First Faculty of Medicine
- Internal Medicine - Hematology +1B00307 | First Faculty of Medicine
- Review of Internal Diseases 1B00341 | First Faculty of Medicine
- Review of Internal Diseases 2B00355 | First Faculty of Medicine
- Ultrasonographic and Endoscopic TechnologyB00816 | First Faculty of Medicine
- Internal Medicine Practice before State Examination +1B01056 | First Faculty of Medicine
- Review of Internal Medicine - Rehabilitation 1B01536 | First Faculty of Medicine
- Diagnosis and therapy in haematology - ethical issuesB02094 | First Faculty of Medicine
- Laboratory Methods in Hematology - Diagnostic Tool and Translation´s Research +1B02551 | First Faculty of Medicine
- News in hematology and blood transfusionB02697 | First Faculty of Medicine
Publications
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Characterization of the input material quality for the production of tisagenlecleucel by multiparameter flow cytometry and its relation to the clinical outcome2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Science
- COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis2023 | First Faculty of Medicine, Third Faculty of Medicine
- Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy2023 | First Faculty of Medicine, Second Faculty of Medicine
- Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- CAR-T lymfocyty v terapii nehodgkinských lymfomů2023 | First Faculty of Medicine
- Polatuzumab vedotin v léčbě agresivních lymfomů2023 | First Faculty of Medicine
Loading network view...